Skip to main content

Salas Salvadó, Jordi

By No Comments

Professor of Nutrition and Director of the Human Nutrition Unit of the Rovira i Virgili University (URV) and Clinical Head of the Nutrition Unit of the Hospital Sant Joan of Reus; Vice-Director of Pere i Virgili Health Research Institute (IISPV) and Investigator of the CIBERobn and coordinator of its Nutrition Program. Director of the Centre Català de la Nutrició de l’Institut d’Estudis Catalans (CCNIEC), Chairman of the World Forum for Nutrition Research and Dissemination (INC); Member of the Scientific Committee of the International Carbohydrate Quality Consortium (ICQ); Member of the Expert Panel of Diabetes and Nutrition Study Group (DSNG) of the European Association for the Study of Diabetes (EASD)

Has been declared by Clarivate Analytics as “Highly Cited Researcher” in the years 2018, 2019 and 2020 as one of the most cited researchers in the world. He has published more than 650 scientific articles, adding more than 25,200 citations and has published 14 books.

Torres Martí, Antoni

By No Comments

Dr Antoni Torres is full profesor of Medicine (Pulmonology) at University of Barcelona. He has been Director and Chief of Pulmonology Department, and Director of the Respiratory Intensive Care Unit at Hospital Clinic of Barcelona. He leads a translational research group focussed on respiratory  infections, ARDS and critical care. His current H-Index is 95. He received several research awards: Edward Shanoff (Harvard University), Josep Trueta, Lilly award, COMB, Icrea Academia, and Murray Korndfel (ACCP).

Zorzano Olarte, Antonio

By No Comments

Antonio Zorzano is  Full Professor of Biochemistry and Molecular Biology at the University of Barcelona, Group Leader at the IRB Barcelona, and Programme Head at CIBERDEM. Professor Zorzano received his PhD in Biology at the University of Barcelona, and did postdoctoral studies at the Hospital Ramon y Cajal, (Madrid), and at Boston University Medical Center. He has supervised  40 Ph.D. theses, is co-inventor of 21 patents, and has published over 300 scientific articles (more than 31,000 citations, h-index of 82, Google Scholar). He has been founder of  biotechnological companies in Spain and in UK.

Professor Zorzano’s research focuses on the regulation of metabolism and its interplay with insulin resistance, obesity and type 2 diabetes. A global goal is to identify and validate molecular targets that permit the prevention or treatment of metabolic diseases  by using cell-based systems, genetically modified mice, and translational approaches.

Villaverde, Antonio

By No Comments

A. Villaverde is a Chair Professor of Microbiology at the Department of Genetics and Microbiology and leader of the Nanobiotechnology group at the IBB, Autonomous University of Barcelona. He coordinates a research team of 20 people, fully integrated in the Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine. He also leads the Applied and Basic Microbiology team of the Generalitat de Catalunya. A. Villaverde has authored around 300 peer-reviewed papers on microbiology-biotechnology-nanoscience interfaces, apart from around 340 communications to conferences, several books, book chapters and 16 patents, among which 7 have been licensed. In 2002, A. Villaverde founded the journal Microbial Cell Factories (ISSN: 1475-2859) and in 2017, the spin-off company Nanoligent SL, devoted to develop precision nanomedicines for cancer. From his publication record, A. Villaverde has received, so far, a total of 11,617 citations, with an h-index of 54.

Surralles Calonge, Jordi

By No Comments

With a PhD in Genetics and postdoctoral experience in The Netherlands (Leiden University Medical Center) and Finland (Finnish Institute of Occupational Health), he set up his research team at the UAB where he is currently Full Professor of Genetics. In 2006, he joined CIBERER as principal investigator. He was later appointed Director of the Genetics Service at Sant Pau UAB Hospital (2017), Scientific Director of Sant Pau Hospital Research Institute (2019) and Director of the Join Unit on Genomic Medicine UAB-IR Sant Pau (2019). He has upervised of >40 research grants from public and private institutions world-wide and participated in clinical trials and multiple contracts with private foundations and biotech-pharma companies. He has given tens of invited lectures in international meetings, published over 130 articles (~8900 citations and H factor: 46) and supervised >30 PhD and Master students.

Ventura Zamora, Salvador

By No Comments

Salvador Ventura is Full Prof. at the Dep. of Biochemistry and Molecular Biology and leader of the Protein Folding and Conformational Diseases group at the Institute of Biotechnology and Biomedicine (IBB), Autonomous University of Barcelona (UAB). He has been director of the IBB in 2017-20. Dr. Ventura has authored more than 240 peer-reviewed research and review papers, apart from several book chapters and 13 patents. He got his Ph. D. in Biology at the UAB in 1998 and worked as postdoctoral fellow (1999-2002) at EMBL-Heidelberg. He has been researcher at Harvard Medical School (USA) and Karolinska Institutet (Sweden) among other centres. He rejoined UAB as a Ramon y Cajal researcher in 2003. Dr. Ventura received the UAB 2008 Excellence Research Award, the Bruker Prize “Manuel Rico” 2020 from the Spanish Biophysical Society and 2009, 2015 and 2020 ICREA-Academia Awards in Life Sciences and Medicine.

Villarroya Gombau, Francesc

By No Comments

My scientific career is fully associated with the direction of my research group, which I started in the mid 90’s, after my previous training in Barcelona, Paris and New York. Since then I have developed an upward research career as PI, financed through competitive funds obtained from public agencies, foundations and private companies. We have participated in numerous European projects and led regional, national and international research networks on the pathophysiological mechanisms of obesity, diabetes and lipodystrophy, including research on the metabolic alterations in HIV patients. I am full professor of Biochemistry and Molecular Biology at UB since 2010. I act as advisor of multiple international research agencies and institutions. I have been director of the Institute of Biomedicine of the UB for 8 years, where I currently hold the position of scientific director. I have been member of steering committees of the CIBERobn and Sociedad Española de Estudio de la Obesidad.

Roca-Cusachs Soulere, Pere

By No Comments

Pere Roca-Cusachs obtained his PhD in cellular biophysics in 2007 from the Medical School at the University of Barcelona. He then worked in the lab of Prof. Michael Sheetz (Columbia University) as a post-doctoral researcher until 2011. He is currently a Serra-Hunter Associate Professor at the University of Barcelona, and Group Leader at the Institute for bioengineering of Catalonia (IBEC). His group studies the physical and molecular mechanisms by which cells detect and respond to mechanical signals.  He currently coordinates an EU-funded Future and Emerging Technologies (FET) project dedicated to understanding the mechanical control of biological function. He is a recipient of the EMBO Young Investigator award, the 2017 City of Barcelona award to the life sciences, and the 2019 Young Investigator Award of the European Biophysical Societies Association (EBSA). He is also an EMBO member.

Ozaita, Andrés

By No Comments

Andrés Ozaita graduated in Biology at the University of the Basque Country (1992). He obtained his PhD degree in Biology (1996) at the University of the Balearic Islands in the field of Neuropharmacology. He did his postdoctoral training at the New York University School of Medicine (1997-2003) focused on the study of the molecular components of neuronal and cardiac excitability. In 2003, he was appointed Ramón y Cajal research fellow in the Department of Experimental and Health Sciences at University Pompeu Fabra. In 2008 he joined the faculty of this department where he is Professor of Pharmacology (2020). He received an American Heart Association postdoctoral award (2001), a Marie Curie International Reintegration Grant (2004). He obtained the Dr. Antoni Esteve Foundation award in Pharmacology research (2011 and 2015) and the Ramon Trias Fargas award (2017) by the Fundació Catalana Síndrome de Down.

Posas Garriga, Francesc

By No Comments

Francesc Posas is Full Professor at the Universitat Pompeu Fabra (UPF) and the Director of IRB Barcelona (Institute for Research in Biomedicine (2018-). After obtaining his doctorate in Biochemistry and Molecular Biology at the Universitat Autònoma de Barcelona (1995), he made a postdoctoral stay at Harvard University (Boston, USA). From 1999 co-leads the Cell Signaling Research Group (https://www.irbbarcelona.org/en/research/cell-signaling). He was the chair of the Department of Health and Experimental Sciences at the UPF (2007-2013), Vice-rector for Science Policy at the UPF (2013-2017) and Commisioner for UPF scientific strategy (2017-2018). Dr. Posas received the award to Young Investigators from the Catalan Government (2001), EMBO Young Investigator Program (2000), EURYI to young investigators (ESF) (2004), EMBO member (2006), awarded with an ICREA Academia (2009-2014) and the “Carmen and Severo Ochoa” Award (2011). Recipient of an ERC Advanced Grant (2012).

ICREA Memoir 2020